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This study compared the effects of toxicity of ethanol and its ﬁ rst metabolite acetaldehyde in rat astrocytes 
through cell viability and cell proliferation. The cells were treated with different concentrations of ethanol in 
the presence or absence of a catalase inhibitor 2-amino-1,2,4 triazole (AMT) or with different concentrations 
of acetaldehyde. Cell viability was assessed using the trypan blue test. Cell proliferation was assessed after 
24 hours and after seven days of exposure to either ethanol or acetaldehyde.
We showed that both ethanol and acetaldehyde decreased cell viability in a dose-dependent manner. In 
proliferation studies, after seven days of exposure to either ethanol or acetaldehyde, we observed a signiﬁ cant 
dose-dependent decrease in cell number. The protein content study showed biphasic dose-response curves, 
after 24 hours and seven days of exposure to either ethanol or acetaldehyde. Co-incubation in the presence 
of AMT signiﬁ cantly reduced the inhibitory effect of ethanol on cell proliferation.
We concluded that long-term exposure of astrocytes to ethanol is more toxic than acute exposure. 
Acetaldehyde is a much more potent toxin than ethanol, and at least a part of ethanol toxicity is due to 
ethanol’s ﬁ rst metabolite acetaldehyde.
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Ethanol consumption has long been associated 
with brain damage. Numerous experimental studies 
and necropsy examinations of chronic alcoholics 
have shown a wide range of structural and functional 
alterations in neurons and astrocytes (1-3). Such 
alterations are also seen in children with the foetal 
alcohol syndrome (4). Astrocytes are the major brain 
cell population; they play an important role in guiding 
migrating neurons during development, in regulating 
neurotransmitter and ion levels, in neuron nutrition, and 
in production of neurotrophic factors (5). Astrocytes 
are also a major site for bioactivation and detoxiﬁ cation 
of neurotoxins (6). Many studies have shown that both 
ethanol and acetaldehyde disturb astroglial growth and 
differentiation; however, the mechanism remained 
elusive (7-11). In addition, a number of ethanol effects, 
including psychopharmacological and neurotoxic 
effects, are believed to be mediated through its ﬁ rst 
metabolite, acetaldehyde (12-14).
Acetaldehyde, derived from peripheral metabolism 
of ethanol, crosses the blood-brain barrier with 
difﬁ culty due to alcohol- and aldehyde-dehydrogenase 
(15). The localisation and relevance of ethanol 
metabolism in the brain is still controversial. The adult 
mammalian brain contains three enzyme systems for 
oxidising ethanol to acetaldehyde: cytochrome P450 
(CYP) 2E1, catalase, and alcohol-dehydrogenase 
(16). Studies of naive rat brain have established 
a crucial role of catalase in oxidising ethanol and 
forming acetaldehyde. In addition, no evidence of 
alcohol dehydrogenase or CYP2E1 in this process 
was found. Metyrapone (CYP inhibitor) or pyrazole 
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(alcohol-dehydrogenase inhibitor) did not affect 
the formation of acetaldehyde from ethanol in rat 
brain homogenates; at the same time, the presence 
of catalase inhibitors 2-amino-1,2,4 triazole (AMT), 
cyanamide, or sodium azide lowered acetaldehyde 
formation in a dose-dependent manner (17-20). 
The enzyme activity is localised exclusively in the 
microperoxisomes of aminergic neurone perikaryons 
and in glial cells (21). Many pieces of data support 
the notion that acetaldehyde is endowed with positive 
reinforcing properties, which play a crucial role in 
mediating ethanol euphoria and pave the way for 
alcohol craving (22). Animals pre-treated with catalase 
inhibitor AMT showed shorter ethanol narcosis period 
and lower mortality (23), less locomotor depression 
(24), blockade of ethanol-induced taste aversion and 
reduction of ethanol intake (25). The brain catalase 
system seems to play a role in the development of 
tolerance to the hypnotic effect of ethanol, but it does 
not alter tolerance to the hypothermic or metabolic 
effects (26).
There is evidence that astrocytes may respond 
to different injuries by altering phenotype, which 
involves upregulation of a large number of molecules 
(27). It was reported that astrocytes in primary cultures 
respond to a range of neurotoxic compounds with a 
biphasic dose-response; response increases at low, 
subtoxic doses, and is followed by a decrease at higher, 
cytotoxic doses (28).
Literature reports separate data for ethanol and 
acetaldehyde effects on astrocyte viability and 
proliferation, obtained with different methods. There 
are no data if ethanol or acetaldehyde provoke biphasic 
response in primary astrocyte cultures.
The aim of this study was to compare the effect 
of ethanol and acetaldehyde toxicity on rat cortical 
astrocytes in primary culture by determining cell 
viability and cell proliferation. Our secondary goal 
was to establish the role of acetaldehyde in ethanol 
toxicity in cultured astrocytes.
MATERIALS AND METHODS
Materials
L-15 Leibowitz medium, foetal bovine serum 
(FBS), Dulbecco’s modiﬁ ed Eagle medium and Ham’s 
nutrient mixture F-12) (DMEM / F12), penicillin-
streptomycin (10,000 IU mL-1 - 10,000 UG mL-1) 
(P/S), and Dulbecco’s phosphate buffered saline (PBS) 
were purchased from Gibco BRL, Life Technologies, 
Paisley, Scotland. Ethanol and acetaldehyde were from 
Merck, Darmstadt, Germany. AMT, staurosporine, 
trypan blue and bovine serum albumin (BSA) were 
obtained from Sigma Chemical Co., St. Louis, USA. 
Bio-Rad protein assay was obtained from Bio-Rad 
Laboratories, Munich, Germany.
Animals
Newborn Wistar rats (postnatal day 2) were 
obtained from our own breeding colony. The animals 
were maintained under constant environmental 
conditions, with an ambient temperature of (22±1) °C, 
relative humidity (55±10) %, and a natural light-
dark cycle. The breeding colony was kept in Ehret 
type 4 cages (Germany); the bedding material was 
Lignocel 3/4. The colony received standard rodent 
diet (Altormin, Germany), and had free access to 
food and water. We used four newborn animals for 
each experiment.
All animal procedures were approved by the 
National Animal Ethical Committee of the Republic 
of Slovenia (licence number 323-02-232/2005/2) and 
were conducted in accordance with the European 
Convention for the protection of vertebrate animals 
used for experimental and other scientiﬁ c purposes 
(ETS 123).
Preparation of astrocyte cultures
Primary cultures of rat cortical astrocytes were 
prepared from the brain of newborn Wistar rats. 
Newborn rats (postnatal day 2) were decapitated and 
the brains removed aseptically.
After removal of meninges, cortices were 
transferred to a Petri dish containing L-15 (Leibowitz) 
medium. The cortices were then mechanically 
dissociated into 10 mL of culture medium consisting 
of DMEM/F12 (1:1), 10 % FBS, 100 U mL-1penicillin, 
and 100 µg mL-1 streptomycin. Cell suspension was 
triturated and plated onto 35 mmol L-1 (2x106 cells 
per dish). Cells were grown at 37 °C in a water-
saturated air environment containing 10 % CO
2
 
until they became conﬂ uent (10 to 12 days). Culture 
medium was changed every 48 hours after plating. The 
cultures were used for treatment with either ethanol 
or acetaldehyde.
The purity of our culture was checked using 
immunocytochemical staining for glial ﬁ brillary acidic 
protein, which is the major component of astrocyte 
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cytoskeleton. The staining indicated that more than 
90 % of the cells in our experimental model were 
astrocytes, which repeats our previous purity results 
(29).
Treatment of the cells
To determine toxic effects of ethanol and 
acetaldehyde after 24 hours of exposure, the cells 
were treated as follows: after the cultures became 
conﬂ uent, culture medium was replaced with 1 mL of 
fresh serum-free medium and the cells were treated with 
different concentrations of either ethanol (50 mmol L-1 
to 1200 mmol L-1) or acetaldehyde (0.25 mmol L-1 
to 150 mmol L-1), for 24 hours. In another set of 
experiments, the cells were pre-treated with catalase 
inhibitor AMT (10 mmol L-1) for six hours, and 
then treated with different concentrations of ethanol 
(50 mmol L-1 to 1200 mmol L-1) for 24 hours.
Ethanol and acetaldehyde effects after seven 
days of exposure were determined as follows: after 
the ﬁ rst medium changing (3rd day after plating) the 
cells were grown in a medium containing different 
concentrations of either ethanol (50 mmol L-1 to 
1200 mmol L-1) in the presence or absence of AMT 
(10 mmol L-1) or acetaldehyde (0.25 mmol L-1 to 
150 mmol L-1) for the next seven days. The medium 
was changed every 48 hours.
Control cells were grown under the same conditions, 
but in the absence of ethanol or acetaldehyde, or were 
treated with 10 mmol L-1 AMT only.
After the treatment, cells from separate dishes 
were used for viability test, cell counting, or protein 
determination.
Determination of cell viability
Cell viability was assessed using the trypan blue 
test according to a modiﬁ ed method of Uliasz and 
Hewett (30) after having treated the cells with different 
concentrations of either ethanol or acetaldehyde for 
24 hours. Positive control cells were treated with 
1 µmol L-1 staurosporine.
After the treatment, the culture medium was 
replaced by 0.1 mL of 0.4 % trypan blue; after 1 
minute of staining, the cultures were rinsed with PBS 
(pH 7.2). Cells excluding the stain were considered 
viable. The number of trypan blue-stained cells and 
trypan blue-free cells was counted using a light 
microscope at 100 x magniﬁ cation. The total number 
of cells scored per experimental point was 100.
Determination of cell proliferation
Cell proliferation was assessed by cell counting and 
protein determination after treatment with different 
concentrations of either ethanol or acetaldehyde for 
24 hours or seven days.
Cells were counted after treatment and removal 
of culture medium using a light microscope at 100 x 
magniﬁ cation (31). The total number of cells scored 
per experimental point was 100.
Proteins were also determined after treatment and 
removal of culture medium, in cells harvested from 
individual dishes, according to the method of Bradford 
(32) using bovine serum albumin as a standard.
Statistical analysis
The results are shown as mean ± standard error 
of mean (SEM) of three independent determinations. 
One-way ANOVA with Tukey’s post hoc test were 
employed to calculate the signiﬁ cance of differences 
between the means. A p-value of <0.05 was considered 
statistically signiﬁ cant.
RESULTS
The effect of ethanol and acetaldehyde on cell 
viability
Incubation of the cultured astrocytes in the 
presence of ethanol for 24 hours did not inﬂ uence 
cell viability until ethanol reached concentration of 
700 mmol L-1. Estimated EC
50 
was 847.9 mmol L-1. 
Pre-treatment with AMT did not diminish the toxic 
effect of ethanol (Figure 1A). Acetaldehyde showed 
much higher toxicity than ethanol; cell viability was 
affected at 25 mmol L-1 of acetaldehyde, with EC
50 
of 
47.2 mmol L-1 (Figure 1B).
The effect of ethanol and acetaldehyde on cell 
proliferation
Below the concentration 700 mmol L-1, acute 
exposure of the cultured astrocytes to ethanol for 24 
hours did not affect the number of cells in the culture, 
either in the presence or absence of AMT (Figure 
2A). Similarly, we did not observe any decrease in 
cell number after acute exposure to acetaldehyde 
until the cut-off concentration of 50 mmol L-1 (Figure 
2B). Protein content showed biphasic effect of ethanol 
(Figure 2C) and acetaldehyde (Figure 2D) after 24 
hours of exposure. Low concentrations stimulated 
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protein production, but it was inhibited at higher 
concentrations of either compound. Pre-incubation 
of the cells with AMT cancelled the biphasic effect 
of ethanol on protein production, and shifted the 
inhibitory effect to higher ethanol concentrations 
(Figure 2C).
Chronic exposure of growing cells to either 
ethanol or acetaldehyde signiﬁ cantly decreased cell 
number in the cultures. The ﬁ rst signiﬁ cant decrease 
in cell number versus control cells after seven 
days of exposure was observed at 200 mmol L-1 of 
ethanol, with an estimated EC
50 
of 240 mmol L-1. 
Figure 1  Effect of ethanol (EtOH) at different concentrations in the presence or absence of catalase inhibitor AMT (10 mmol L-1) 
(A) and acetaldehyde (ACH) (B) on the viability of cultured astrocytes after 24 hours of exposure. Each point is the 
mean ± SEM of three independent determinations. c1, control cells - growth medium; c2, control cells, treated with 
10 mmol L-1 AMT; c3, control cells, treated with 1 µmol L-1 staurosporine.
Figure 2  Effect of ethanol (EtOH) at different concentrations in the presence or absence of catalase inhibitor AMT (10 mmol L-1) 
on cell count (A) and protein content (C) in cell culture, after 24 hours of incubation. Effect of acetaldehyde (ACH) at 
different concentrations on cell count (B) and protein content (D) in cell culture, after 24 hours of incubation. Each 
bar is the mean ± SEM of three independent determinations. *p<0.05 versus control c1; °p<0.05 versus values with 
the same ethanol concentration in the absence of AMT. c1, control cells - growth medium; c2, control cells, treated 
with 10 mmol L-1 AMT.
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Pre-incubation with AMT reduced ethanol inﬂ uence 
on proliferation by 24.1 %, with EC
50 
rising to 
436.7 mmol L-1 (Figure 3C).
After seven days of exposure, acetaldehyde 
inhibited cell growth at much lower concentrations 
than ethanol; the ﬁ rst signiﬁ cant decrease in cell 
number was observed at 5 mmol L-1 acetaldehyde 
(Figure 3B). EC
50 
was 13 mmol L-1. Protein content 
ﬁ rst signiﬁ cantly dropped at 5 mmol L-1 acetaldehyde, 
with EC
50 
8.7 mmol L-1 (Figure 3D).
DISCUSSION
Although brain damage associated with chronic 
consumption of ethanol is multifactorial and depends 
on a number of ethanol effects on the central nervous 
system, some data suggest that oxidative metabolism 
of ethanol and produced substances are involved in 
the aetiology of these effects (33). Many studies have 
shown that both ethanol and acetaldehyde disturb 
astroglial growth and differentiation; however, the 
mechanism has remained elusive (8, 11, 34-39).
There are reports that ethanol at high concentrations 
intercalates into cell membranes, increasing membrane 
ﬂ uidity (40). In our study we have shown that ethanol 
at high concentrations (700 mmol L-1 and above) 
affects cell viability in primary rat cultures. This result 
is no surprise, because astrocytes are fairly resistant 
cell species with high antioxidant capacity. Compared 
to ethanol, acetaldehyde was much more potent; its 
ﬁ rst signiﬁ cant effect on cell viability was seen at a 
much lower concentration (50 mmol L-1).
Astrocytes are the most abundant brain cells. As 
such, they also provide metabolic and trophic support 
to neurones. Astrocytes are able to respond to an 
injury with altered phenotype. In such conditions they 
respond with increased production of intermediate 
ﬁ laments and structural glial ﬁ brillary protein, with 
cell hypertrophy, and sometimes with cell proliferation 
Figure 3  Effect of ethanol (EtOH) at different concentrations in the presence or absence of catalase inhibitor AMT on cell 
count (A) and protein content (C) in cell culture after seven days of incubation. Effect of acetaldehyde (ACH) at 
different concentrations on cell count (B) and protein content (D) in cell culture after seven days of incubation. Each 
bar is the mean ± SEM of three independent determinations. *p<0.05 versus control c1; °p<0.05 versus values with 
the same ethanol concentration in absence of AMT. c1, control cells - growth medium; c2, control cells, treated with 
10 mmol L-1 AMT.
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(41). This could explain the biphasic, hormetic 
dose-response effect, which we obtained in the cell 
proliferation test by measuring cell protein content.
We observed the biphasic effect of ethanol after 
24 hours and after seven days of exposure; low 
concentrations of ethanol stimulated protein production, 
whereas higher concentrations inhibited it.
Astrocytes have a high antioxidant capacity. In 
oxidative stress, they react with upregulation of a large 
number of molecules including those controlling the 
protective system. Therefore, they can protect neurons 
against toxic damage (42). Watts et al. (43) showed 
the protective effect of co-cultured astrocytes on 
neurons, reducing the apoptosis rate after 12-hour and 
24-hours exposure to 55 mmol L-1 and 88 mmol L-1 of 
ethanol. Neuron protection could be also speculated 
in our study at ethanol doses of 25 mmol L-1 and 
50 mmol L-1, with significant increase in protein 
content after acute exposure. However, protein 
upregulation was  blocked by pretreatment of astrocyte 
cultures with catalase inhibitor AMT, which decreased 
acetaldehyde production and, in turn, could have 
decreased the production of reactive oxygen species 
(ROS). Decreased ROS level production by neurons 
co-cultured with astrocytes during the second hour of 
exposure to 55 mmol L-1 and 88 mmol L-1 of ethanol 
was also found by Watts et al. (43).
Both ethanol and acetaldehyde inhibited astrocyte 
growth after seven days of exposure in a dose-
dependent manner, but acetaldehyde was much more 
toxic. Their inhibitory effect on proliferation was 
conﬁ rmed by low cell count and low protein content 
in cultures. The ﬁ rst signiﬁ cant decrease in cell count 
versus control was observed at 100 mmol L-1 of 
ethanol, and the ﬁ rst signiﬁ cant difference in protein 
content was seen at 300 mmol L-1. This difference 
could be related to the common astrocyte response 
to low doses of toxicants by altering the phenotype, 
which in turn leads to upregulation of a large number 
of molecules protecting the cell (28). According to 
basic toxicological data for acute oral toxicity in rats, 
acetaldehyde is 10 to 20 times a more potent toxin 
than alcohol (44). Our results for acetaldehyde go 
along these lines, as we observed the ﬁ rst signiﬁ cant 
decrease in cell count versus control at 5 mmol L-1.
The mechanism of action of ethanol on astroglial 
growth is still subject to debate. Proliferation of 
astrocytes is mainly controlled by soluble mitogenic 
factors such as growth factors acting on tyrosine 
kinase-coupled receptors (45, 46). Ethanol has been 
shown to inhibit basal astroglial proliferation and 
response to mitogenic factors such as IGF-1 and 
acetylcholine (35, 47). Ethanol (e.g., 30 mmol L-1 to 
250 mmol L-1) inhibits cell proliferation (34, 48) and 
reduces incorporation of [3H] thymidine (49). High 
concentrations of ethanol alter cell-cycle kinetics of 
proliferating astrocytes by delaying the passage of the 
cells trough G1 (49). These effects appear to be dose-
dependent. At low concentrations (e.g., 14 mmol L-1) 
ethanol increases DNA, RNA, and protein synthesis 
(43). Ethanol also increases astrocyte death, both by 
necrosis and apoptosis (11).
A number of ethanol effects,  including 
psychopharmacological and neurotoxic effects, 
are believed to be mediated by its ﬁ rst metabolite, 
acetaldehyde. However, there are only a few data 
about the cytotoxicity of acetaldehyde in astrocytes. 
Acetaldehyde, but not ethanol, increases intracellular 
calcium level, elevates transglutaminase activity, 
and causes signiﬁ cant DNA fragmentation and cell 
nuclei chromatin condensation in astrocytes (50). We 
have shown that pretreatment with catalase inhibitor 
AMT signiﬁ cantly diminishes ethanol toxicity (28 % 
lower after 24 hours of exposure and 24.1 % lower 
after seven days of exposure). Our results are also 
in accordance with one of the rare reports about 
acetaldehyde production in cultured astrocytes, 
where 10 mmol L-1 AMT decreased acetaldehyde 
metabolism from ethanol by 52 % (51). 
To conclude, both ethanol and acetaldehyde show 
toxic effects on cultured astrocytes and both inhibit 
proliferation, which depends on the concentration and 
time of exposure. Long-term exposure of astrocytes 
to either ethanol or acetaldehyde is more toxic than 
acute exposure. Acetaldehyde is a much more potent 
toxin than ethanol. Moreover, at least a part of ethanol 
toxicity is due to its metabolising to acetaldehyde. Our 
study may contribute to better understanding of the 
involvement of ethanol and its oxidative metabolite 
acetaldehyde in the development of foetal alcohol 
syndrome due to ethanol exposure during pregnancy 
and in the development of morphological and 
functional changes in the CNS in chronic alcoholics.
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Izvleček
PRIMERJAVA TOKSIČNOSTI ETANOLA IN ACETALDEHIDA ZA PODGANJE ASTROCITE V 
PRIMARNI KULTURI
V študiji smo primerjali toksičnost etanola in njegovega prvega metabolita acetaldehida za podganje 
astrocite z določitvijo celične viabilnosti in proliferacije. Celične kulture smo tretirali z različnimi 
koncentracijami etanola, etanola v prisotnosti inhibitorja katalaze 2-amino-1,2,4 triazol-a (AMT) ali z 
različnimi koncentracijami acetaldehida. Celično viabilnost smo vrednotili s pomočjo testa s tripanskim 
modrilom, celično proliferacijo pa s štetjem celic in določitvijo koncentracije proteinov po 24-urni, kot 
tudi 7-dnevni izpostavljenosti.
S študijo smo pokazali, da tako etanol kot tudi acetaldehid v odvisnosti od njune koncentracije zmanjšata 
celično viabilnost. V študiji proliferacije sta etanol in acetaldehid, v odvisnosti od njunih koncentracij, 
značilno zmanjšala število celic po 7-dnevni izpostavljenosti. Pri ugotavljanju vsebnosti proteinov smo 
dobili bifazno krivuljo tako po 24-urni, kot tudi po 7-dnevni izpostavljenosti različnim koncentracijam 
etanola oziroma acetaldehida. Prisotnost AMT je signiﬁ kantno zmanjšala učinek etanola na celično 
proliferacijo.
Zaključimo lahko, da je dolgotrajna izpostavljenost astrocitov etanolu bolj toksična kot akutna. Acetaldehid 
je močnejši toksin kot etanol in vsaj del toksičnosti etanola je posledica delovanja njegovega prvega 
metabolita, acetaldehida.
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